Author: dxnimble

medical-alert-systems13Jun

NIMBLE Diagnostics: Non-invasive medical technology used to monitor patients with implanted coronary stents
Societal challenge: No method for proactively monitoring implanted stents NIMBLE Diagnostics’ novel technology will make waves in the medical community and in the treatment of cardiovascular disease. Atherosclerosis is the leading cause of most cardiovascular diseases, as it often forms blood clots and causes a restriction of oxygen-rich blood flow to the tissues. This blockage can cause various diseases, such as coronary artery disease, stroke, peripheral arterial disease, and aneurysms. Stents are small, metallic tubes implanted in the location of the obstruction to restore blood flow or other fluids. Initially, …
dayone-stent03Mar

NIMBLE Diagnostics: DayOne Innovation Summit
DayOne Innovation Summit 4FYN hosted by Fundacion la Caixa in Barcelona, Spain. At this conference, innovation and technology were celebrated in a gathering of ingenious companies aiming to change the world through technology and new ideas. Congratulations to Sycai Medical on their award, and we look forward to continuing to develop and change lives. …
nimble-diagnostics-cardiology-stent03Feb

Winner of Barcelona Activa Technology Grant
NIMBLE Diagnostics had recognition once more for its innovation and groundbreaking technology. This past week NIMBLE participated in and won first place in an accelerator program organized by Barcelona Activa and Grow Venture Partners. This program was created for early-stage technology projects, disruptive technologies, and technology in the validation stage in laboratory environments. NIMBLE competed against 7 selected projects and was judged by a panel of 4 experts, pushing the revolutionary technology to the final round where NIMBLE was judged by a panel of 19 professionals. After careful deliberation, NIMBLE was chosen for …
igtp-medicine-cardiac-stent15Ene

NIMBLE Diagnostics Closed Funding of Over 1 million Euros
Awarded 1.000.000 Euros NIMBLE Diagnostics’ funding has shown immense success. NIMBLE Diagnostics has successfully closed a funding round led by Grow Venture Partners together with Namarel Ventures and Inveniam Group. They have secured over 1 million euros to continue their mission of saving lives through preventative care. NIMBLE Diagnostics is a spin-off company of experts in the cardiology field of Germans Trias i Pujol Research Institute (IGTP), the Universitat Politècnica de Catalunya (UPC) – BarcelonaTech and the Universitat de Barcelona. They are all working together to create a medical technology device, the first of …
heart-stent-innovation15Nov

E-nnova Health 2022 Award Winner: NIMBLE Diagnostics
E-nnova Health Award NIMBLE Diagnostics was recognized once more for its innovation and revolutionary technology. At the Pablo XI Foundation in Madrid, Spain, CEO of NIMBLE Diagnostics Dr. Oriol Iborra Egea accepted the 2022 E-nnova Health Award in honor of NIMBLE’s innovation in medical technology and drive to save lives through preventative medicine. Follow us on LinkedIn to keep up to date on our transformative journey. …
nimble-diagnostics-angiography15Oct

NIMBLE Diagnostics Innovation: Healthcare Investment Forum
NIMBLE Diagnostics presents at the Healthcare Investment Forum NIMBLE Diagnostics’ innovation was presented once more at another medical conference highlighting new technology in the medical field. At the 31st Barcelona Healthcare Investment Forum organized by Biocat, Barcelona Medical Association (COMB), Barcelona-Activa-Barcelona City Council, and ESADE-BAN. NIMBLE Diagnostics was one of the eight companies chosen to present and represent innovation in present-day medicine. …

NIMBLE Diagnostics provides peace of mind to patients and clinicians by developing innovative medical devices. The device is currently in the regulatory submission phase.

  • IGTP Institut Germans Tries i Pujol
     Camí de les Escoles, s/n
    08916 Badalona, Barcelona
Explore
Contact us